Full-Time

Director – Salesforce Service Cloud Solutions

Confirmed live in the last 24 hours

Natera

Natera

1,001-5,000 employees

Genetic testing and diagnostics solutions provider

Compensation Overview

$1/hr

Senior, Expert

Company Historically Provides H1B Sponsorship

San Carlos, CA, USA

Category
Project Management
Strategy Development
Business & Strategy
Required Skills
Salesforce
Data Analysis
Requirements
  • Bachelor’s degree in Healthcare Administration, Business, Computer Science, or related field (Master’s preferred).
  • 15+ years of CRM experience with 10+ years in Salesforce Service Cloud leadership, including in healthcare or life sciences.
  • Strong knowledge of healthcare CRM use cases—provider management, patient outreach, contact center optimization, and referral growth.
  • Familiarity with Salesforce Health Cloud, Experience Cloud, Marketing Cloud, and Lightning components.
  • Proven track record deploying AI and Mulesoft RPA technologies to optimize CRM processes and drive operational efficiency.
  • Understanding of healthcare compliance requirements: HIPAA, HITECH, CCPA, etc.
  • Demonstrated experience with AI in CRM, case management automation, and Salesforce analytics.
  • Excellent leadership, stakeholder engagement, and vendor management skills.
  • Salesforce certifications (e.g., Salesforce Administrator, Sales Cloud Consultant, Service Cloud Consultant) strongly preferred.
  • Hands-on experience with Salesforce platform architecture and automation tools (e.g., Flows, Process Builder, Apex).
  • Strong domain knowledge in sales pipeline management, service case workflows, SLAs, and customer journey optimization.
Responsibilities
  • Lead the strategic roadmap and implementation of Salesforce Service Cloud to support global customer and patient service operations ensuring CRM capabilities align with evolving business needs
  • Champion the use of Salesforce Agentforce AI for predictive service to lead the transformation of our contact center operations across customer and patient journeys
  • Partner with digital, operations, IT, and care teams to transform service journeys across channels (phone, email, portal, SMS, chat).
  • Deploy RPA solutions to streamline repetitive tasks, reduce manual overhead, and boost workforce productivity across the sales and service lifecycle. Collaborate with data, automation, and business teams to deliver end-to-end intelligent process automation.
  • Own the strategy, design, implementation, and governance of Salesforce Sales and Service Cloud for healthcare sales and support functions.
  • Collaborate with business leaders across provider outreach, referral networks, care coordination, contact centers, and sales teams to align CRM capabilities with operational and clinical goals.
  • Integrate Salesforce with potential 3rd-party apps to enhance the healthcare engagement lifecycle.
  • Drive CRM data governance, interoperability, and alignment with EHR, ERP, CDP, and analytics systems.
  • Leverage AI and automation (e.g., Salesforce Einstein, GPT-based service assistants, auto case routing) to streamline workflows and improve care team productivity.
  • Ensure the CRM environment is secure, scalable, and compliant with HIPAA, CCPA, and other healthcare data regulations.
  • Lead cross-functional delivery teams, internal CRM admins/developers, and external implementation partners to execute the CRM roadmap.
  • Measure success through KPIs such as provider satisfaction, sales pipeline velocity, case resolution times, and patient engagement outcomes
  • Build and lead a high-performing team of Salesforce developers, business analysts, admins, and offshore resources.
Desired Qualifications
  • Experience in life sciences, biotech, or other regulated industries.
  • Familiarity with tools such as UiPath, Automation Anywhere, or Salesforce-native RPA solutions.
  • Salesforce certifications (e.g., Service Cloud Consultant, Application Architect).
  • Expertise with SaaS application strategy, cloud migration, and enterprise integration.

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and monitor organ health. Natera stands out by offering specialized tests like the Signatera ctDNA test and Panorama NIPT, along with genetic counseling services. The company's goal is to improve patient care through precise genetic insights.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Austin, Texas

Founded

2004

Simplify Jobs

Simplify's Take

What believers are saying

  • Rising demand for personalized medicine supports Natera's genetic testing services.
  • The global NIPT market is expected to reach $7.3 billion by 2025.
  • Increased adoption of liquid biopsy tests aligns with Natera's cfDNA focus.

What critics are saying

  • Expansion into new Austin space could strain financial resources.
  • Increased competition from companies like Lantheus Holdings threatens market share.
  • HEROES trial for breast cancer may face regulatory hurdles or delays.

What makes Natera unique

  • Natera specializes in cell-free DNA testing for diverse medical applications.
  • Their Signatera test offers personalized ctDNA analysis for cancer patients.
  • Natera's Panorama NIPT has conducted over 2 million non-invasive prenatal tests.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible medical plans

Investment options

Time off

Workplace perks

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

-1%

2 year growth

5%
PRWeb
May 30th, 2025
The Melanoma Research Foundation To Host The Denver Miles For Melanoma 5K

The Melanoma Research Foundation (MRF) is thrilled to announce the next event in its annual Miles for Melanoma nationwide 5K program, bringing together local melanoma patients, supporters, care partners and thrivers. This year we will be hosting our annual Denver event on Saturday, June 14, 2025 at Sloan Lake Park at 7:30 AM MT. Opening Ceremonies will start at 8:30 AM MT and our race will kick off promptly at 9:00 AM MT. We are excited to share that Kyle Speller, PA Announcer for the Denver Nuggets, will be returning as our emcee on event day! We're also excited to welcome back local sponsor, Cara Mia Dermatology, who will be providing free on-site skin screenings—helping our community stay sun-safe while supporting a great cause.DENVER, May 29, 2025 /PRNewswire-PRWeb/ -- The Melanoma Research Foundation (MRF) is thrilled to announce the next event in its annual Miles for Melanoma nationwide 5K program, bringing together local melanoma patients, supporters, care partners and thrivers. This year we will be hosting our annual Denver event on Saturday, June 14, 2025 at Sloan Lake Park at 7:30 AM MT. Opening Ceremonies will start at 8:30 AM MT and our race will kick off promptly at 9:00 AM MT

Intelligence360
May 15th, 2025
Natera To Spend $9.9 Million To Occupy 30,000 Square Feet Of Space In Austin Texas.

Natera to spend $9.9 Million to occupy 30,000 square feet of space in Austin Texas. Natera to spend $9.9 Million to occupy 30,000 square feet of space in Austin Texas.Austin, Texas — According to state and local development sources, Natera plans to invest $9,900,000.00 to build out 30,000 square feet of new space in Austin. The company plans to occupy the new space at 13011A McCallen Pass in Austin, on or about January 1, 2026. According to the company website Natera is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, womens health, and organ health. Our aim is to make personalized genetic testing and diagnostics part of the standard of care to protect health and enable earlier and more targeted interventions that lead to longer, healthier lives. Where some set out to build a test, we set out to achieve a mission: change the management of disease worldwide by using DNA testing to proactively inform treatment

TXBN
Apr 24th, 2025
Natera Announces Broad Clinical Launch of Ultra-Sensitive Signatera(TM) Genome MRD Test

Natera announces broad clinical launch of ultra-sensitive signatera(tm) genome MRD test.

Slater Sentinel
Apr 3rd, 2025
DnB Asset Management AS Invests $235,000 in Natera, Inc. (NASDAQ:NTRA)

DnB Asset Management AS invests $235,000 in Natera, Inc. (NASDAQ:NTRA).

TXBN
Mar 25th, 2025
DEFINE-HT Selected for Late-Breaking Oral Presentation at ISHLT Annual Meeting

AUSTIN, Texas - (BUSINESS WIRE) - Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, announced that it will share results from the DEFINE-HT study in a late-breaking oral presentation at the International Society for Heart and Lung Transplantation (ISHLT) 45th Annual Meeting on April 29, 2025.